keyboard_arrow_up

Global In-Vitro Diagnostic Market Research Insights, 2015-2021

Global In-Vitro Diagnostic Market Research and Analysis, 2015-2021 is a new market research publication announced by Reportstack. The Global In-Vitro Diagnostic Market is expected to grow at a CAGR of 6% during 2015-2021. The Global In-Vitro Diagnostic Market is growing at a modest rate due to technological advancement and R&D in diagnostic devices and test. Rising fatal diseases such as CVD, CHD, Stroke, Cancer and other heart diseases are driving the global In vitro diagnostic market. Investment from government and private players are creating huge scope in global In Vitro Diagnostic Market. Successful clinical trials and rise in patents are boosting the market growth and creating considerable scope in Global In-Vitro Diagnostic Market. Global In-Vitro Diagnostic Market by applications such as diabetes, infectious diseases, oncology, nephrology, autoimmune diseases and cardiology are generating huge revenues across the globe. Global In-Vitro Diagnostic Market by end user such as hospitals, laboratory, point of care testing are adopted significantly in developed and emerging economies due to rising life style oriented diseases and improvement in healthcare spending.

Global In-Vitro Diagnostic Market by usability includes disposable IVD devices and re-usable IVD devices which are widely adopted across the globe. The Global In-Vitro Diagnostics Market is growing at a steady growth rate due to some other pivotal factors such as FDA clearance to diagnostic devices and successful clinical trials in vitro biomarkers. As a result there are variety of in vitro diagnostic medicines and devices which are used to diagnose and test various fatal diseases across the globe. Global In-Vitro Diagnostics Market products enable the physicians and doctors to diagnose the patient on time and avoid worsening of life style oriented diseases such as CVD, CHD, Cancer, Diabetes and other lingering diseases. Adoption of minimal invasive technologies and their technological advancement are creating huge scope for Global In-Vitro Diagnostics Market. Global In-Vitro Diagnostics Market by products such as Data Management Software/Hardware, Reagents & Kits and Instruments are widely adopted and contributes considerably in the growth of Global In-Vitro Diagnostics Market.

To access full report with TOC, please visit Global In-Vitro Diagnostic Market Research and Analysis, 2015-2021.

Geographical Insights
North America contributes highest in Global In-Vitro Diagnostic Market followed by Europe. The key drivers of the significant contribution of North America is the rising adoption of In-Vitro Diagnostic due to rise in life style oriented diseases such as Cancer, CVD, CHD, Stroke and other heart diseases. Emerging economies such as China, India, Japan and Korea has huge customer base and improved healthcare spending which are expected to create huge opportunity for Global In-Vitro Diagnostic Market. Improved standard of living, infrastructural development and favorable government policies are other factors that are driving the APAC market. The report includes detailed Market Overview, Market Determinants, Company Profiling, Sector Analysis, Market Segmentation, Geographical Analysis, Pipeline Analysis, Patent Analysis, Strategic Recommendations, Key Company Analysis, GAP Analysis, Key Findings, Market Estimations, Market Insights, Analyst Insights and predictive analysis of the market. 

Competitive Insights:
The Key players of Global In-Vitro Diagnostic Market includes: Abbott Laboratories, Inc., Johnson and Johnson, Becton, Dickson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc. Other players contributing considerably to the Global In Vitro Diagnostic Market which includes Bio-Rad Laboratories, Inc., Alere, Inc. Hologic Inc, KEM-EN-TEC Diagnostics Inc, Medtronic, Omega Diagnostics Group, Ortho Clinical Diagnostics, Inc., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Atlas Genetics Ltd., Elitech Group, Biomerieux, Transasia Bio-Medicals, Werfen Group and so on. In-Vitro Diagnostic companies are constantly focusing on R&D, partnerships, product launch, M&A, innovation and technological advancement.

Market Segmentation:
Global In-Vitro Diagnostic Market is segmented on the basis of application, type, end user, usability and geography. Global In-Vitro Diagnostic Market by application includes diseases such as Cardiology, Oncology, Nephrology, infectious diseases, autoimmune diseases, diabetes and HIV/AIDS. Global In-Vitro Diagnostic Market by application are in huge demand and contributing significantly in generating revenues across the globe. Global In-Vitro Diagnostics Market by end user includes hospitals, laboratories, diagnostic centers, point of care testing and other end users. Emerging economies such as India, China, Japan and Korea are expected to contribute significantly in Global In-Vitro Diagnostic Market due to rising life style oriented diseases and improving healthcare spending.


Companies Mentioned

1. ABBOTT LABORATORIES, INC. 2. ALERE INC 3. ATLAS GENETICS LIMITED 4. BECTON, DICKINSON AND COMPANY 5. BIOMÉRIEUX 6. BIO-RAD LABORATORIES, INC. 7. DANAHER CORPORATION 8. ELITECH GROUP 9. ELITECH GROUP 10. JOHNSON & JOHNSON 11. KEM-EN-TEC DIAGNOSTICS INC 12. MEDTRONIC 13. OMEGA DIAGNOSTICS GROUP 14. ORTHO CLINICAL DIAGNOSTICS, INC. 15. ROCHE DIAGNOSTICS 16. SIEMENS HEALTHCARE 17. SYSMEX CORPORATION 18. THERMO FISHER SCIENTIFIC, INC. 19. TRANSASIA BIO-MEDICALS 20. WERFEN GROUP

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###